Your browser doesn't support javascript.
loading
Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
Johansson, Gunnar; Mushnikov, Vasili; Bäckström, Tobias; Engström, Andreas; Khalid, Javaria Mona; Wall, Jennifer; Hoti, Fabian.
Afiliación
  • Johansson G; Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
  • Mushnikov V; EPID Research, Metsänneidonkuja 12, FI-02130, Espoo, Finland.
  • Bäckström T; Takeda Pharmaceuticals, Stockholm, Sweden.
  • Engström A; Takeda Pharmaceuticals, Stockholm, Sweden.
  • Khalid JM; Takeda Development Centre Europe, London, UK.
  • Wall J; EPID Research, Metsänneidonkuja 12, FI-02130, Espoo, Finland.
  • Hoti F; EPID Research, Metsänneidonkuja 12, FI-02130, Espoo, Finland. Fabian.Hoti@epidresearch.com.
BMC Pulm Med ; 18(1): 17, 2018 Jan 25.
Article en En | MEDLINE | ID: mdl-29370846
BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) are an important measure of disease severity in terms of impaired disease progression, increased recovery time, healthcare resource utilization, overall morbidity and mortality. We aimed to quantify exacerbation and healthcare resource utilization rates among COPD patients in Sweden with respect to baseline treatments, exacerbation history, and comorbidities. METHODS: Patients with a COPD or chronic bronchitis (CB) diagnosis in secondary care at age of ≥40 years on 1.7.2009 were identified and followed until 1.7.2010 or death. Severe exacerbations were defined as hospitalizations due to respiratory disease, and healthcare resource utilization was measured by all-cause hospitalizations and secondary care visits. Poisson regression was used adjusting for age, gender, time since COPD/CB diagnosis, and Charlson comorbidity index. RESULTS: In 88,548 patients (54% females, mean age 72 years), previous respiratory hospitalizations and current high use of COPD medication (double or triple therapy) predicted an 8.3-fold increase in severe exacerbation rates and 1.8-fold increase in healthcare resource utilization rates in the following year, compared to patients without combination treatment and/or history of severe exacerbations. CONCLUSIONS: COPD/CB patients with history of severe exacerbations and high use of COPD medication experienced a significantly increased rate of severe exacerbations and healthcare resource utilization during the one-year follow-up.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bronquitis Crónica / Enfermedad Pulmonar Obstructiva Crónica / Recursos en Salud / Hospitalización Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Pulm Med Año: 2018 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bronquitis Crónica / Enfermedad Pulmonar Obstructiva Crónica / Recursos en Salud / Hospitalización Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Pulm Med Año: 2018 Tipo del documento: Article País de afiliación: Suecia